Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma

BACKGROUND: Synovial sarcoma is a high-grade malignant tumor of soft tissue, characterized by the specific chromosomal translocation t(X;18), and its resultant SYT-SSX fusion gene. Despite intensive multimodality therapy, the majority of metastatic or relapsed diseases still remain incurable, thus s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kawaguchi, Satoshi, Wada, Takuro, Ida, Kazunori, Sato, Yuriko, Nagoya, Satoshi, Tsukahara, Tomohide, Kimura, Sigeharu, Sahara, Hiroeki, Ikeda, Hideyuki, Shimozawa, Kumiko, Asanuma, Hiroko, Torigoe, Toshihiko, Hiraga, Hiroaki, Ishii, Takeshi, Tatezaki, Shin-ichiro, Sato, Noriyuki, Yamashita, Toshihiko
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2005
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC545052/
https://ncbi.nlm.nih.gov/pubmed/15647119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-3-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados